Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001447028-25-000115
Filing Date
2025-08-06
Accepted
2025-08-06 07:32:07
Documents
68
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q abus-20250630.htm   iXBRL 10-Q 966984
2 EX-31.1 a2025-q210xqex311.htm EX-31.1 10600
3 EX-31.2 a2025-q210xqex312.htm EX-31.2 10686
4 EX-32.1 a2025-q210xqex321.htm EX-32.1 4880
5 EX-32.2 a2025-q210xqex322.htm EX-32.2 4898
11 abus-20250630_g1.jpg GRAPHIC 56927
  Complete submission text file 0001447028-25-000115.txt   5742599

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abus-20250630.xsd EX-101.SCH 41589
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abus-20250630_cal.xml EX-101.CAL 43696
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abus-20250630_def.xml EX-101.DEF 217178
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abus-20250630_lab.xml EX-101.LAB 539030
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abus-20250630_pre.xml EX-101.PRE 381360
71 EXTRACTED XBRL INSTANCE DOCUMENT abus-20250630_htm.xml XML 681944
Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

EIN.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34949 | Film No.: 251187467
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)